Digitale Bibliotheek
Sluiten Bladeren door artikelen uit een tijdschrift
     Tijdschrift beschrijving
       Alle jaargangen van het bijbehorende tijdschrift
         Alle afleveringen van het bijbehorende jaargang
                                       Alle artikelen van de bijbehorende aflevering
 
                             29 gevonden resultaten
nr titel auteur tijdschrift jaar jaarg. afl. pagina('s) type
1 Acetyl-CoA synthetase 2 enhances tumorigenesis and is indicative of a poor prognosis for patients with renal cell carcinoma Zhang, Shaojin

40 7 p. 355
artikel
2 Age of menarche and primary bladder cancer risk: A meta-analysis and systematic review Li, Ya-Dong

40 7 p. 346.e17-346.e26
artikel
3 Comparing costs of renal preservation versus radical nephroureterectomy management among patients with non-metastatic upper tract urothelial carcinoma Williams, Stephen B.

40 7 p. 345.e1-345.e7
artikel
4 Corrigendum to definitive and sustained increase in prostate cancer metastases in the United States Patel, Neal A.

40 7 p. 354
artikel
5 Corrigendum to: Mechanistic target of rapamycin (mTOR) protein expression in the tumor and its microenvironment correlates with more aggressive pathology at cystectomy Winters, Brian R.

40 7 p. 352
artikel
6 Corrigendum to ‘miR-145 inhibits invasion of bladder cancer cells by targeting PAK1’ Kou, Bo

40 7 p. 349-351
artikel
7 Corrigendum to “Urinary incontinence and erectile dysfunction in patients with localized or locally advanced prostate cancer: A nationwide observational study” Vernooij, R.W.M.

40 7 p. 353
artikel
8 Cover 2 - Masthead
40 7 p. IFC
artikel
9 Differential efficacy of ablation therapy versus partial nephrectomy between clinical T1a and T1b renal tumors: A systematic review and meta-analysis Yanagisawa, Takafumi

40 7 p. 315-330
artikel
10 Disparities in patient and system factors explain racial/ethnic disparities in delayed time to treatment in muscle invasive bladder cancer Buac, Neil P.

40 7 p. 343.e15-343.e20
artikel
11 Effectiveness of pembrolizumab in patients with urothelial carcinoma receiving proton pump inhibitors Fukuokaya, Wataru

40 7 p. 346.e1-346.e8
artikel
12 Healthcare costs and resource utilization associated with renal cell carcinoma among older Americans: A longitudinal case-control study using the SEER-Medicare data Bhandari, Naleen Raj

40 7 p. 347.e17-347.e27
artikel
13 Intravesical instillation with glycosaminoglycan replacement treatment in patients suffering radiation-induced haemorrhagic cystitis: When and which patients can benefit most from it? Sanguedolce, Francesco

40 7 p. 344.e19-344.e25
artikel
14 Introduction McConkey, David J.

40 7 p. 277-278
artikel
15 Mitomycin C allergy after passive and device-assisted hyperthermia for non-muscle invasive bladder cancer treatment: A retrospective cohort from a high-volume center González-Padilla, Daniel Antonio

40 7 p. 345.e19-345.e23
artikel
16 Molecular tumor heterogeneity in muscle invasive bladder cancer: Biomarkers, subtypes, and implications for therapy da Costa, Jose Batista

40 7 p. 287-294
artikel
17 Mutational landscape of non-muscle-invasive bladder cancer Hurst, Carolyn D.

40 7 p. 295-303
artikel
18 Mutation signatures to Pan-Cancer Atlas: Investigation of the genomic landscape of muscle-invasive bladder cancer Cooley, Lauren Folgosa

40 7 p. 279-286
artikel
19 Patient reported outcomes and health related quality of life in localized prostate cancer: A review of current evidence Kord, Eyal

40 7 p. 304-314
artikel
20 Percentage of sarcomatoid histology is associated with survival in renal cell carcinoma: Stratification and implications by clinical metastatic stage Patel, Hiten D.

40 7 p. 347.e1-347.e8
artikel
21 Prognostic value of the fluctuation in the neutrophil–lymphocyte ratio at 6 weeks of pembrolizumab treatment is specific to the clinical response in metastatic urothelial carcinoma Uchimoto, Taizo

40 7 p. 344.e11-344.e17
artikel
22 Quality of life in low-income men after surgical castration for metastatic prostate cancer Gaither, Thomas W.

40 7 p. 343.e7-343.e14
artikel
23 Reduced CDH16 expression is linked to poor prognosis in clear cell renal cell carcinoma 16 Lennartz, Maximilian

40 7 p. 348.e1-348.e8
artikel
24 Robotic-assisted tumor enucleation versus standard margin partial nephrectomy: Perioperative, renal functional, and oncologic outcomes for low and intermediate complexity renal masses Patel, Hiten D.

40 7 p. 347.e9-347.e16
artikel
25 Salvage partial gland ablation for recurrent prostate cancer following primary partial gland ablation: Functional and oncological outcomes Qaoud, Yazan

40 7 p. 343.e1-343.e6
artikel
26 The design basis and application in urology of the tumor-on-a-chip platform Sheng, Fei

40 7 p. 331-342
artikel
27 The prognostic value of urinary cytology after trimodal therapy (TMT) for muscle-invasive bladder cancer McLoughlin, Louise C.

40 7 p. 346.e9-346.e16
artikel
28 The safety, tolerability, and efficacy of a neoadjuvant gemcitabine intravesical drug delivery system (TAR-200) in muscle-invasive bladder cancer patients: a phase I trial Daneshmand, Siamak

40 7 p. 344.e1-344.e9
artikel
29 Value of MRI in evaluating urachal carcinoma: A single center retrospective study Das, Jeeban P.

40 7 p. 345.e9-345.e17
artikel
                             29 gevonden resultaten
 
 Koninklijke Bibliotheek - Nationale Bibliotheek van Nederland